New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice.-论文-万方医学网

第一作者： Andreas K,Lindner

第一单位： Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Institute of Tropical Medicine and International Health, Berlin, Germany.

作者： Andreas K,Lindner ^[1] ; Veerle,Lejon ^[2] ; François,Chappuis ^[3] ; Jorge,Seixas ^[4] ; Leon,Kazumba ^[5] ; Michael P,Barrett ^[6] ; Erick,Mwamba ^[7] ; Olema,Erphas ^[8] ; Elie A,Akl ^[9] ; Gemma,Villanueva ^[10] ; Hanna,Bergman ^[10] ; Pere,Simarro ^[11] ; Augustin,Kadima Ebeja ^[12] ; Gerardo,Priotto ^[11] ; Jose Ramon,Franco ^[11]

作者单位： Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Institute of Tropical Medicine and International Health, Berlin, Germany. ^[1] Intertryp, Institut de Recherche pour le Développement, CIRAD, University of Montpellier, Montpellier, France. Electronic address: veerle.lejon@ird.fr. ^[2] Hôpitaux Universitaires de Genève, Geneva, Switzerland. ^[3] Institute of Hygiene and Tropical Medicine and Global Health and Tropical Medicine R&D Center, NOVA University, Lisbon, Portugal. ^[4] Neurology Department, University of Kinshasa, Kinshasa, Democratic Republic of the Congo. ^[5] Wellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow, UK. ^[6] National HAT Control Program, Ministry of Health, Kinshasa, Democratic Republic of the Congo. ^[7] National HAT Control Program, Ministry of Health, Kampala, Uganda. ^[8] AUB GRADE Center, Center for Systematic Reviews in Health Policy and Systems Research, American University of Beirut, Beirut, Lebanon. ^[9] Cochrane Response, London, UK. ^[10] Neglected Tropical Diseases Department, World Health Organization, Geneva, Switzerland. ^[11] World Health Organization Office for the Democratic Republic of Congo, Kinshasa, Democratic Republic of Congo. ^[12]

医学主题词青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗原虫药(Antiprotozoal Agents);儿童(Child);儿童, 学龄前(Child, Preschool);依氟鸟氨酸(Eflornithine);女(雌)性(Female);人类(Humans);婴儿(Infant);婴儿, 新生(Infant, Newborn);男(雄)性(Male);中年人(Middle Aged);硝呋替莫(Nifurtimox);硝基咪唑类(Nitroimidazoles);诊疗准则(主题)(Practice Guidelines as Topic);布鲁斯锥虫冈比亚亚种(Trypanosoma brucei gambiense);锥虫病, 非洲(Trypanosomiasis, African);世界卫生组织(World Health Organization);青年人(Young Adult)

DOI 10.1016/S1473-3099(19)30612-7

PMID 31879061

发布时间 2021-01-10

基金项目

001/WHO_/World Health Organization/International

检索历史清除

New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice.

The Lancet. Infectious diseases

相似文献

同项目论文

The Lancet. Infectious diseases

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

New WHO guidelines for treatment of gambiense human African trypanosomiasis including fexinidazole: substantial changes for clinical practice.

The Lancet. Infectious diseases

相似文献

同项目论文

The Lancet. Infectious diseases

相关期刊

检索历史清除